<DOC>
	<DOCNO>NCT00162942</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Adacolumn Apheresis System treatment sign symptoms Crohn 's disease .</brief_summary>
	<brief_title>Study Treatment Crohn 's Disease With Adacolumn</brief_title>
	<detailed_description>Trial Features : - Medical device ( Non-drug option ) - Most patient remain current treatment regimen throughout study Components Study : - Study length 24 week , include screen visit , ten treatment visit nine week 4 follow-up appointment - Physical exam , laboratory test disease assessment conduct charge patient - 2:1 Randomization ( treatment : sham ) - Open-Label extension offer eligible patient</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Key Moderate severe Crohn 's disease Adequate peripheral venous access Agree participate require followup visit Able complete diary Signed write informed consent document authorization use protect health information Key Extremely severe Crohn 's disease Known obstructive symptom within past 3 month Presence toxic megacolon Major surgery within past 6 week anticipate need surgery within 12 week Total colectomy , ileostomy , stoma 100 cm resect small bowel Requiring inpatient hospitalization A history allergic reaction heparin heparininduced thrombocytopenia A history hypersensitivity reaction associate apheresis procedure intolerance apheresis procedures A history severe cardiovascular peripheral arterial diseases A history cerebral vascular disease Liver diseases Renal insufficiency Known bleeding disorder use concomitant anticoagulant therapy purpose apheresis treatment Any hypercoagulable disorder Known infection Hepatitis B C , HIV Severe anemia Leukopenia granulocytopenia Evidence current systemic infection Malignancy Pregnant , lactate plan become pregnant course investigational study Used within last 30 day , investigational drug , biologic device 5 halflives , know , investigational drug biologic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>